Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Blaise

Showing results (21-30 of 510) with videos related to

Pageof 51
Sort By:
Haematologica|July 4, 2007
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Odile Avinens, Catherine Faucher, et al.
Journal of Leukocyte Biology|September 29, 2020
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapyRaynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, et al.
Haematologica|July 2, 2015
Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMTSalyka Sengsayadeth, Bipin N Savani, Didier Blaise, et al.
Haematologica|September 12, 2006
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationHugues de Lavallade, Mohamad Mohty, Catherine Faucher, et al.
Leukemia & Lymphoma|November 1, 2012
Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureThomas Prebet, Aude Charbonnier, Véronique Gelsi-Boyer, et al.
British Journal of Haematology|October 3, 2002
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitorsMohamad Mohty, Daniel Isnardon, Norbert Vey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2017
Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib BitherapySelim Sid, Jerome Rey, Aude Charbonnier, et al.
Bulletin Du Cancer|November 12, 2003
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]Mohamad Mohty, Béatrice Gaugler, Boris Calmels, et al.
Bone Marrow Transplantation|July 27, 2024
Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxisLining Wang, Wenhui Gao, Ling Wang, et al.
Bone Marrow Transplantation|March 4, 2020
REBOUND "Trained to live again": The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantationDidier Blaise, Sarah Calvin, Sarah Cuvelier, et al.
Pageof 51

Showing results (21-30 of 510) with videos related to

Sort By:
Pageof 51
Haematologica|July 4, 2007
Predictive factors and impact of full donor T-cell chimerism after reduced intensity conditioning allogeneic stem cell transplantationMohamad Mohty, Odile Avinens, Catherine Faucher, et al.
Journal of Leukocyte Biology|September 29, 2020
Mechanisms of NK cell dysfunction in the tumor microenvironment and current clinical approaches to harness NK cell potential for immunotherapyRaynier Devillier, Anne-Sophie Chrétien, Thomas Pagliardini, et al.
Haematologica|July 2, 2015
Reduced intensity conditioning allogeneic hematopoietic cell transplantation for adult acute myeloid leukemia in complete remission - a review from the Acute Leukemia Working Party of the EBMTSalyka Sengsayadeth, Bipin N Savani, Didier Blaise, et al.
Haematologica|September 12, 2006
Low-dose methotrexate as salvage therapy for refractory graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantationHugues de Lavallade, Mohamad Mohty, Catherine Faucher, et al.
Leukemia & Lymphoma|November 1, 2012
Lenalidomide treatment for patients with myelodysplastic syndrome and low blast count acute myeloid leukemia after azacitidine failureThomas Prebet, Aude Charbonnier, Véronique Gelsi-Boyer, et al.
British Journal of Haematology|October 3, 2002
Low blood dendritic cells in chronic myeloid leukaemia patients correlates with loss of CD34+/CD38- primitive haematopoietic progenitorsMohamad Mohty, Daniel Isnardon, Norbert Vey, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2017
Treatment of Post-transplant Relapse of FLT3-ITD Mutated AML Using 5-Azacytidine and Sorafenib BitherapySelim Sid, Jerome Rey, Aude Charbonnier, et al.
Bulletin Du Cancer|November 12, 2003
[Immunotherapy of acute myeloid leukemias: development of vaccines and cell therapy approaches]Mohamad Mohty, Béatrice Gaugler, Boris Calmels, et al.
Bone Marrow Transplantation|July 27, 2024
Impact of graft CD34+ cell counts on hematological recovery in patients receiving post-transplant cyclophosphamide prophylaxisLining Wang, Wenhui Gao, Ling Wang, et al.
Bone Marrow Transplantation|March 4, 2020
REBOUND "Trained to live again": The practice of great Olympic coaches improves and enhances the quality of life of cancer patients in remission after hematopoietic stem cell allogeneic transplantationDidier Blaise, Sarah Calvin, Sarah Cuvelier, et al.
Pageof 51